Apic Bio

Apic Bio

Apic Bio

#Biotech developing #GeneTherapy treatment for rare diseases including #Alpha1 antitrypsin deficiency
Founded
2017
Raised
$41M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$40,000,000
Venture capital (Series A) - 2019
Morningside Ventures Morningside Venture Capital
$1,000,000
Seed fund - 2017
Edward Krapels Alpha-1 Foundation
Team Size
2
Employees
$40,000,000 Venture capital (Series A)
ChinaMoneyNetwork , FinSMEs , PE HUB

Morningside Venture Invests Series A Round In US Gene Therapy Company

$1,000,000 Seed fund
biospace

Biotech Gene Therapy Startup Apic Bio Launches in Cambridge Massachusetts